OPRX
OptimizeRx Corp
Company overview
- Market capitalization
- $147.11M
- Employees
- 132
- Latest publication
- 2026-09-29
About OptimizeRx Corp
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q4 20242024-12-31 · USD | Q4 20232023-12-31 · USD | Q4 20222022-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 20,504,000USD | 19,844,000USD | 32,239,000USD | 26,067,000USD | 29,195,000USD | 32,316,000USD | 28,368,946USD | 19,654,457USD |
| Cost Of Revenue | 4,816,000USD | 5,976,000USD | 8,139,000USD | 8,551,000USD | 10,560,000USD | 10,293,000USD | 10,527,640USD | 7,200,029USD |
| Gross Profit | 15,688,000USD | 13,868,000USD | 24,100,000USD | 17,516,000USD | 18,635,000USD | 22,023,000USD | 17,841,306USD | 12,454,428USD |
| Research Development | 3,274,000USD | 3,402,000USD | — | 80,000USD | — | 71,000USD | — | — |
| Selling General Administrative | 3,702,000USD | 3,513,000USD | 14,085,000USD | 14,326,000USD | 14,372,000USD | 17,295,000USD | 18,858,352USD | 15,034,181USD |
| Selling And Marketing Expenses | 5,528,000USD | 4,729,000USD | — | 60,000USD | — | — | — | — |
| General And Administrative Expenses | 3,702,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 15,776,000USD | 13,472,000USD | 15,163,000USD | 15,466,000USD | 15,446,000USD | 18,389,000USD | 30,392,220USD | 13,318,776USD |
| Operating Income | -88,000USD | 396,000USD | 8,937,000USD | 2,049,999USD | 3,189,000USD | 3,634,000USD | -2,023,274USD | -864,348USD |
| Total Other Income Expense Net | -1,008,000USD | -1,040,000USD | -1,466,000USD | -1,000,999USD | -1,476,000USD | -1,426,000USD | — | 538,512USD |
| Interest Income | 81,000USD | 77,000USD | 84,000USD | 91,000USD | 90,000USD | 98,000USD | 117,608USD | 538,512USD |
| Interest Expense | 1,127,000USD | 1,155,000USD | 1,241,000USD | 1,154,000USD | 1,603,000USD | 1,563,000USD | — | 538,512USD |
| Income Before Tax | -1,096,000USD | -644,000USD | 7,471,000USD | 1,049,000USD | 1,713,000USD | 2,208,000USD | -11,739,328USD | -325,836USD |
| Income Tax Expense | -393,000USD | -149,000USD | 2,451,000USD | 270,000USD | 181,000USD | 2,286,000USD | — | -538,512USD |
| Net Income | -703,000USD | -495,000USD | 5,020,000USD | 779,000USD | 1,532,000USD | -78,000USD | -4,141,406USD | -325,836USD |
| Unclassified Operating Expenses | — | 1,828,000USD | 1,078,000USD | — | 1,074,000USD | 1,023,000USD | 11,533,868USD | -1,715,405USD |
| Net Interest Income | — | -1,078,000USD | -1,157,000USD | -1,063,000USD | -1,513,000USD | -1,465,000USD | -1,336,156USD | 538,512USD |
| Tax Provision | — | -149,000USD | 2,451,000USD | 270,000USD | 181,000USD | 2,286,000USD | -7,597,922USD | 0USD |
| Net Income From Continuing Ops | — | -495,000USD | 5,020,000USD | 779,000USD | 1,532,000USD | -78,000USD | -4,141,406USD | -325,836USD |
| Ebit | — | 511,000USD | 8,712,000USD | 2,203,000USD | 3,316,000USD | 3,771,000USD | — | -325,836USD |
| Ebitda | — | 1,575,000USD | 9,790,000USD | 3,144,000USD | 4,390,000USD | 4,865,000USD | — | 130,709USD |
| Depreciation And Amortization | — | 1,064,000USD | 1,078,000USD | 941,000USD | 1,074,000USD | 1,094,000USD | — | 456,545USD |
| Reconciled Depreciation | — | 1,064,000USD | 1,078,000USD | 1,081,000USD | 1,074,000USD | 1,094,000USD | 1,006,228USD | 456,545USD |
| Non Operating Income Net Other | — | — | — | — | — | — | — | 538,512USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | — | -325,836USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20212021-12-31 · USD | FY 20182018-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD | FY 20112011-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 109,429,000USD | 61,292,598USD | 21,206,363USD | 7,220,678USD | 6,502,962USD | 4,957,016USD | 2,048,699USD | 1,111,520USD |
| Cost Of Revenue | 40,161,000USD | 25,654,384USD | 8,999,666USD | 3,622,203USD | 3,221,534USD | 1,767,425USD | 115,360USD | — |
| Gross Profit | 69,268,000USD | 35,638,214USD | 12,206,697USD | 3,598,475USD | 3,281,428USD | 3,189,591USD | 1,933,339USD | 1,111,520USD |
| Selling General Administrative | 50,245,000USD | 27,514,023USD | 9,994,278USD | 3,273,634USD | 3,366,649USD | 2,732,914USD | 2,168,722USD | 2,021,426USD |
| Unclassified Operating Expenses | 6,962,000USD | 2,086,454USD | 1,056,672USD | — | — | — | — | — |
| Total Operating Expenses | 57,207,000USD | 35,277,114USD | 12,026,565USD | 4,195,882USD | 3,907,756USD | 2,973,990USD | 2,413,044USD | 2,565,497USD |
| Operating Income | 12,061,000USD | 361,100USD | 180,132USD | -597,407USD | -1,026,328USD | 215,601USD | -364,345USD | -1,453,977USD |
| Interest Income | 353,000USD | 16,979USD | 46,212USD | 2,270USD | — | — | — | — |
| Interest Expense | 5,294,000USD | 121,129USD | 0USD | 0USD | 0USD | 0USD | 100USD | 958,641USD |
| Net Interest Income | -4,941,000USD | 16,979USD | 46,212USD | — | — | — | — | — |
| Income Before Tax | 6,950,000USD | 378,079USD | 226,344USD | -595,140USD | -1,025,393USD | 215,847USD | -363,976USD | -2,120,762USD |
| Income Tax Expense | 1,818,000USD | 104,150USD | 46,212USD | 2,267USD | 0USD | 426USD | 469USD | 958,641USD |
| Tax Provision | 1,818,000USD | 0USD | 0USD | — | — | — | — | — |
| Net Income | 5,132,000USD | 378,079USD | 226,344USD | -595,140USD | -1,025,393USD | 215,847USD | -363,976USD | -2,120,762USD |
| Net Income From Continuing Ops | 5,132,000USD | 378,079USD | 226,344USD | -595,140USD | -1,025,393USD | 215,601USD | -363,776USD | — |
| Ebit | 12,244,000USD | 378,079USD | 920,302USD | -595,140USD | -1,025,393USD | 216,027USD | -454,453USD | -1,162,121USD |
| Ebitda | 16,571,000USD | 2,343,404USD | 1,236,804USD | -261,190USD | -761,053USD | 409,818USD | -267,349USD | -1,016,806USD |
| Depreciation And Amortization | 4,327,000USD | 1,965,325USD | 316,502USD | 333,950USD | 264,340USD | 193,791USD | 187,104USD | 145,315USD |
| Reconciled Depreciation | 4,327,000USD | 1,965,325USD | 316,502USD | — | — | — | — | — |
| Total Other Income Expense Net | -5,111,000USD | 16,979USD | 46,212USD | 2,267USD | 935USD | 246USD | 369USD | -666,785USD |
| Selling And Marketing Expenses | — | 5,676,637USD | 299,955USD | 47,927USD | 87,201USD | 47,105USD | 57,218USD | 544,071USD |
| Non Operating Income Net Other | — | 16,979USD | 46,212USD | 2,267USD | 935USD | — | 469USD | — |
| Net Income Applicable To Common Shares | — | 378,079USD | 226,344USD | -595,140USD | -1,025,393USD | 215,601USD | -363,776USD | — |
| Research Development | — | — | 675,660USD | 290,371USD | 189,566USD | 130,288USD | 126,923USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 164,317,000USD | 167,264,000USD | 176,918,000USD | 170,321,000USD | 169,265,000USD | 167,768,000USD | 171,168,000USD | 165,199,000USD |
| Cash And Equivalents | 24,096,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 54,146,000USD | 56,165,000USD | 64,715,000USD | 56,320,000USD | 54,080,000USD | 51,711,000USD | 53,971,000USD | 46,906,000USD |
| Total Liabilities | 33,235,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 9,711,000USD | 10,459,000USD | 21,264,000USD | 18,466,000USD | 21,057,000USD | 18,351,000USD | 18,654,000USD | 14,502,000USD |
| Other Current Liabilities | 5,389,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 131,082,000USD | 129,610,999USD | 128,294,000USD | 122,263,000USD | 119,284,000USD | 116,270,000USD | 116,998,000USD | 114,465,000USD |
| Total Equity Including Noncontrolling Interest | 131,082,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 1,250,000USD | 2,000,000USD | 4,255,000USD | 3,300,000USD | 3,300,000USD | 3,300,000USD | 2,000,000USD | 2,000,000USD |
| Long Term Debt | 17,757,000USD | 21,343,000USD | 21,421,000USD | 24,801,000USD | 25,127,000USD | 29,190,000USD | 30,816,000USD | 33,278,000USD |
| Deferred Revenue | 709,000USD | — | — | — | — | — | — | — |
| Net Receivables | 24,796,000USD | 32,860,000USD | 38,504,000USD | 33,974,000USD | 34,158,000USD | 32,833,000USD | 38,212,000USD | 26,391,000USD |
| Property Plant Equipment Net | 574,000USD | 459,000USD | 510,000USD | 600,000USD | 662,000USD | 453,000USD | 516,000USD | 583,000USD |
| Goodwill | 70,869,000USD | — | — | — | — | — | — | — |
| Accounts Payable | 1,323,000USD | 3,066,000USD | 1,636,000USD | 2,037,000USD | 1,982,000USD | 3,381,000USD | 2,156,000USD | 2,754,000USD |
| Short Term Debt | 227,000USD | 2,177,000USD | 4,448,000USD | 3,507,000USD | 3,509,000USD | 3,439,000USD | 2,168,000USD | 2,195,000USD |
| Common Stock | 21,000USD | 21,000USD | 20,000USD | 20,000USD | 20,000USD | 20,000USD | 20,000USD | 20,000USD |
| Retained Earnings | -80,434,000USD | -79,731,000USD | -79,236,000USD | -84,256,000USD | -85,035,000USD | -86,567,000USD | -84,368,000USD | -84,290,000USD |
| Accumulated Other Comprehensive Income | 11,000USD | — | — | 0USD | — | — | — | — |
| Intangible Assets | — | 39,753,000USD | 40,796,000USD | 42,437,000USD | 43,492,000USD | 44,506,000USD | 45,516,000USD | 46,479,000USD |
| Other Current Assets | — | 3,136,000USD | 2,846,000USD | 2,827,000USD | 3,337,000USD | 2,305,000USD | 2,379,000USD | 4,389,000USD |
| Total Liab | — | 37,653,000USD | 48,624,000USD | 48,058,000USD | 49,981,000USD | 51,498,000USD | 54,170,000USD | 50,734,000USD |
| Other Current Liab | — | 4,547,000USD | 14,677,000USD | 12,527,000USD | 15,082,000USD | 11,020,000USD | 13,539,000USD | 8,767,000USD |
| Capital Stock | — | 21,000USD | 20,000USD | 20,000USD | 20,000USD | 20,000USD | 20,000USD | 20,000USD |
| Good Will | — | 70,869,000USD | 70,869,000USD | 70,869,000USD | 70,869,000USD | 70,869,000USD | 70,869,000USD | 70,869,000USD |
| Cash | — | 20,169,000USD | 23,365,000USD | 19,519,000USD | 16,585,000USD | 16,573,000USD | 13,380,000USD | 16,126,000USD |
| Cash And Short Term Investments | — | 20,169,000USD | 23,365,000USD | 19,519,000USD | 16,585,000USD | 16,573,000USD | 13,380,000USD | 16,126,000USD |
| Current Deferred Revenue | — | 669,000USD | 503,000USD | 395,000USD | 484,000USD | 511,000USD | 473,000USD | 786,000USD |
| Net Debt | — | 3,547,000USD | 2,738,000USD | 9,089,000USD | 12,390,000USD | 16,227,000USD | 19,813,000USD | 19,589,000USD |
| Short Long Term Debt Total | — | 23,716,000USD | 26,103,000USD | 28,608,000USD | 28,975,000USD | 32,800,000USD | 33,193,000USD | 35,715,000USD |
| Property Plant Equipment Gross | — | 459,000USD | 861,000USD | 600,000USD | 662,000USD | 453,000USD | 774,000USD | 583,000USD |
| Common Stock Shares Outstanding | — | 18,761,622shares | 19,381,024shares | 19,021,905shares | 19,015,496shares | 18,470,808shares | 18,418,519shares | 18,323,542shares |
| Non Current Assets Total | — | 111,099,000USD | 112,203,000USD | 114,001,000USD | 115,185,000USD | 116,057,000USD | 117,197,000USD | 118,293,000USD |
| Non Current Liabilities Total | — | 27,194,000USD | 27,360,000USD | 29,592,000USD | 28,924,000USD | 33,147,000USD | 35,516,000USD | 36,232,000USD |
| Non Currrent Assets Other | — | 18,000USD | 28,000USD | 95,000USD | 162,000USD | 229,000USD | 296,000USD | 362,000USD |
| Net Working Capital | — | 45,706,000USD | 43,451,000USD | 37,854,000USD | 33,023,000USD | 33,360,000USD | 35,317,000USD | 32,404,000USD |
| Unclassified Current Liabilities | — | -2,000,000USD | -4,255,000USD | -3,300,000USD | -3,300,000USD | -3,300,000USD | -1,682,000USD | -2,000,000USD |
| Unclassified Non Current Liabilities | — | 5,851,000USD | 5,939,000USD | 4,791,000USD | 3,797,000USD | 3,957,000USD | 4,700,000USD | 2,954,000USD |
| Unclassified Equity | — | 209,299,999USD | 207,490,000USD | 206,479,000USD | 204,279,000USD | 202,797,000USD | 201,326,000USD | 198,715,000USD |
| Inventory | — | — | — | — | — | — | — | -4,389,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 176,918,000USD | 171,168,000USD | 183,373,898USD | 134,651,185USD | 140,985,192USD | 60,327,754USD | 56,638,525USD | 25,054,578USD |
| Intangible Assets | 40,796,000USD | 45,516,000USD | 49,395,582USD | 13,022,911USD | 10,646,654USD | 12,120,944USD | 13,940,142USD | 5,259,067USD |
| Other Current Assets | 2,846,000USD | 2,379,000USD | 3,189,468USD | 2,280,828USD | 5,630,655USD | 4,456,611USD | 871,043USD | 590,744USD |
| Total Liab | 48,624,000USD | 54,170,000USD | 56,820,724USD | 8,540,408USD | 9,605,475USD | 10,353,840USD | 11,776,266USD | 6,596,133USD |
| Total Stockholder Equity | 128,294,000USD | 116,998,000USD | 126,553,174USD | 126,110,777USD | 131,379,717USD | 49,973,914USD | 44,862,259USD | 18,458,445USD |
| Other Current Liab | 14,677,000USD | 13,539,000USD | 13,211,482USD | 6,591,686USD | 7,281,052USD | 9,001,042USD | 4,919,073USD | 3,209,498USD |
| Common Stock | 20,000USD | 20,000USD | 19,899USD | 18,289USD | 17,861USD | 15,223USD | 14,601USD | 12,039USD |
| Capital Stock | 20,000USD | 20,000USD | 19,899USD | 18,289USD | 17,861USD | 15,223USD | 14,601USD | 12,039USD |
| Retained Earnings | -79,236,000USD | -84,368,000USD | -64,257,964USD | -46,692,098USD | -35,253,658USD | -35,631,737USD | -33,424,610USD | -30,278,805USD |
| Good Will | 70,869,000USD | 70,869,000USD | 78,357,074USD | 22,673,820USD | 14,740,031USD | 14,740,031USD | 14,740,031USD | 3,678,513USD |
| Cash | 23,365,000USD | 13,380,000USD | 13,852,456USD | 18,208,685USD | 84,681,770USD | 10,516,776USD | 18,852,680USD | 8,914,034USD |
| Cash And Short Term Investments | 23,365,000USD | 13,380,000USD | 13,852,456USD | 74,140,506USD | 84,681,770USD | 10,516,776USD | 18,852,680USD | 8,914,034USD |
| Total Current Assets | 64,715,000USD | 53,971,000USD | 54,330,892USD | 98,576,635USD | 115,113,010USD | 32,859,092USD | 27,141,748USD | 15,962,619USD |
| Total Current Liabilities | 21,264,000USD | 18,654,000USD | 17,881,125USD | 8,395,876USD | 9,368,749USD | 10,028,307USD | 6,107,513USD | 4,231,133USD |
| Current Deferred Revenue | 503,000USD | 473,000USD | 171,841USD | 164,309USD | 1,389,907USD | 285,795USD | 580,014USD | 610,625USD |
| Net Debt | 2,738,000USD | 19,813,000USD | 22,971,344USD | -17,974,251USD | -84,354,062USD | -10,068,023USD | -18,288,496USD | -8,914,034USD |
| Short Term Debt | 4,448,000USD | 2,168,000USD | 2,221,625USD | 89,902USD | 90,982USD | 123,220USD | 115,431USD | — |
| Short Long Term Debt | 4,255,000USD | 2,000,000USD | 2,000,000USD | — | — | — | — | — |
| Short Long Term Debt Total | 26,103,000USD | 33,193,000USD | 36,823,800USD | 234,434USD | 327,708USD | 448,753USD | 564,184USD | — |
| Long Term Debt | 21,421,000USD | 30,816,000USD | 34,230,737USD | — | — | — | — | — |
| Net Receivables | 38,504,000USD | 38,212,000USD | 37,288,968USD | 22,155,301USD | 24,800,585USD | 17,885,705USD | 7,418,025USD | 6,457,841USD |
| Accounts Payable | 1,636,000USD | 2,156,000USD | 2,227,177USD | 1,549,979USD | 606,808USD | 618,250USD | 492,995USD | 411,010USD |
| Property Plant Equipment Net | 510,000USD | 516,000USD | 722,302USD | 372,768USD | 472,638USD | 594,828USD | 735,877USD | 149,330USD |
| Property Plant Equipment Gross | 861,000USD | 774,000USD | 873,164USD | 372,768USD | 472,638USD | 594,828USD | 735,877USD | 149,330USD |
| Common Stock Shares Outstanding | 18,998,463shares | 18,292,935shares | 17,124,801shares | 17,783,992shares | 17,690,489shares | 14,827,923shares | 13,387,863shares | 11,862,991shares |
| Non Current Assets Total | 112,203,000USD | 117,197,000USD | 129,043,006USD | 36,074,550USD | 25,872,182USD | 27,468,662USD | 29,496,777USD | 9,091,959USD |
| Non Current Liabilities Total | 27,360,000USD | 35,516,000USD | 38,939,599USD | 144,532USD | 236,726USD | 325,533USD | 5,668,753USD | 2,365,000USD |
| Non Currrent Assets Other | 28,000USD | 296,000USD | 568,048USD | 5,051USD | 12,859USD | 12,859USD | 80,727USD | 5,049USD |
| Net Working Capital | 43,451,000USD | 35,317,000USD | 36,449,767USD | 90,180,759USD | 105,744,261USD | 22,830,785USD | 21,034,235USD | 11,731,486USD |
| Unclassified Current Liabilities | -4,255,000USD | -1,682,000USD | -1,951,000USD | — | — | — | — | — |
| Unclassified Non Current Liabilities | 5,939,000USD | 4,700,000USD | 4,708,862USD | — | — | — | -5,220,000USD | -2,365,000USD |
| Unclassified Equity | 207,490,000USD | 201,326,000USD | 190,771,340USD | 172,767,511USD | 166,597,653USD | 85,575,205USD | 78,257,667USD | 48,817,874USD |
| Other Assets | — | — | 1USD | 5,051USD | 12,859USD | 12,859USD | 80,727USD | 235,647USD |
| Short Term Investments | — | — | 0USD | 55,931,821USD | 0USD | — | — | — |
| Accumulated Other Comprehensive Income | — | — | 0USD | 0USD | — | — | 0USD | -104,702USD |
| Inventory | — | — | — | 1,807,176USD | -5,630,649,369,345USD | — | — | — |
| Treasury Stock | — | — | — | -1,214USD | — | — | — | — |
| Non Current Liabilities Other | — | — | — | 236,726USD | 236,726USD | 325,533USD | 5,668,753USD | 2,365,000USD |
| Net Tangible Assets | — | — | — | 131,379,717USD | 105,993,032USD | 49,973,914USD | 16,182,086USD | 9,520,865USD |
| Unclassified Current Assets | — | — | — | -1,807,176USD | — | — | — | — |
| Other Liab | — | — | — | — | — | — | 5,220,000USD | 2,365,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 2,128,000USD |
| Stock Based Compensation | 4,036,000USD |
| Change To Account Receivables | 12,956,000USD |
| Change To Liabilities | -6,503,000USD |
| Change In Working Capital | 12,562,000USD |
| Operating Cash Flow | 8,144,000USD |
| Capital Expenditures | -56,000USD |
| Investing Cash Flow | -56,000USD |
| Net Debt Issuance | -63,206,000USD |
| Net Common Stock Issuance | -63,000USD |
| Unclassified Financing Cash Flow | 55,901,000USD |
| Financing Cash Flow | -7,368,000USD |
| Effect Of Forex Changes On Cash | 11,000USD |
| Change In Cash | 731,000USD |
| End Cash Flow | 24,096,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -495,000USD | 5,020,000USD | 779,000USD | 1,532,000USD | -2,199,000USD | -79,000USD | -9,124,000USD | -4,008,000USD |
| Depreciation | 1,064,000USD | 1,078,000USD | 1,081,000USD | 1,074,000USD | 1,094,000USD | 1,094,000USD | 1,095,000USD | 1,073,000USD |
| Stock Based Compensation | 1,828,000USD | 1,960,000USD | 1,956,000USD | 1,488,000USD | 1,558,000USD | 2,936,000USD | 2,603,000USD | 2,903,000USD |
| Other Non Cash Items | 358,000USD | -522,000USD | 174,000USD | 765,000USD | 174,000USD | 117,000USD | 14,087,000USD | 181,000USD |
| Change To Account Receivables | 5,763,000USD | -3,460,000USD | -780,000USD | -1,325,000USD | 5,492,000USD | -12,935,000USD | -1,805,000USD | 5,227,000USD |
| Change In Working Capital | -3,222,000USD | -1,663,000USD | -788,000USD | 30,000USD | 3,237,000USD | -5,495,000USD | -5,245,000USD | 633,000USD |
| Total Cash From Operating Activities | -467,000USD | 7,088,000USD | 3,202,000USD | 4,561,000USD | 3,864,000USD | 198,000USD | 1,791,000USD | 782,000USD |
| Capital Expenditures | -21,000USD | -11,000USD | -10,000USD | -10,000USD | -27,000USD | -120,000USD | -92,000USD | -85,000USD |
| Free Cash Flow | -488,000USD | 7,077,000USD | 3,192,000USD | 4,551,000USD | 3,837,000USD | 78,000USD | 1,699,000USD | 697,000USD |
| Total Cashflows From Investing Activities | -21,000USD | 206,000USD | -10,000USD | -44,000USD | -84,000USD | -120,000USD | -92,000USD | -85,000USD |
| Net Borrowings | -2,691,000USD | -2,500,000USD | -500,000USD | -4,500,000USD | -500,000USD | -2,500,000USD | -500,000USD | — |
| Total Cash From Financing Activities | -2,708,000USD | -3,448,000USD | -258,000USD | -4,505,000USD | -587,000USD | -2,824,000USD | -532,000USD | -915,000USD |
| Sale Purchase Of Stock | -17,000USD | — | -96,000USD | -5,000USD | -87,000USD | -324,000USD | -32,000USD | -415,000USD |
| Change In Cash | -3,196,000USD | 3,846,000USD | 2,934,000USD | 12,000USD | 3,193,000USD | -2,746,000USD | 1,167,000USD | -218,000USD |
| Begin Period Cash Flow | 23,365,000USD | 19,519,000USD | 16,585,000USD | 16,573,000USD | 13,380,000USD | 16,126,000USD | 14,959,000USD | 15,177,000USD |
| End Period Cash Flow | 20,169,000USD | 23,365,000USD | 19,519,000USD | 16,585,000USD | 16,573,000USD | 13,380,000USD | 16,126,000USD | 14,959,000USD |
| Other Cashflows From Financing Activities | -17,000USD | -962,000USD | 338,000USD | -5,000USD | -87,000USD | -324,000USD | -32,000USD | -415,000USD |
| Other Cashflows From Investing Activities | — | 217,000USD | — | -34,000USD | -57,000USD | -103,000USD | -195,000USD | -40,000USD |
| Unclassified Operating Cash Flow | — | 1,215,000USD | — | — | — | 1,625,000USD | -1,625,000USD | — |
| Investments | — | — | -10,000USD | -44,000USD | -84,000USD | -120,000USD | -92,000USD | -85,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 5,132,000USD | -20,110,000USD | -17,566,000USD | -11,438,440USD | 378,079USD | -2,207,127USD | -3,142,576USD | 226,344USD |
| Depreciation | 4,327,000USD | 4,329,000USD | 2,402,000USD | 2,022,029USD | 1,965,325USD | 2,075,888USD | 1,282,787USD | 316,502USD |
| Stock Based Compensation | 6,962,000USD | 11,466,000USD | 13,717,000USD | 15,745,822USD | 5,491,957USD | 3,172,840USD | 2,260,298USD | 1,863,911USD |
| Other Non Cash Items | 264,000USD | 6,834,000USD | 9,757,000USD | 363,512USD | 80,000USD | 140,390USD | 635,000USD | 656,934USD |
| Change To Account Receivables | 460,000USD | -2,168,000USD | -8,713,000USD | 2,281,773USD | -6,994,880USD | -10,667,680USD | -548,830USD | -2,789,252USD |
| Change In Working Capital | 816,000USD | 921,000USD | -15,550,000USD | 3,961,155USD | -7,189,322USD | -9,692,377USD | -1,798,345USD | -2,273,537USD |
| Total Cash From Operating Activities | 18,715,000USD | 4,889,000USD | -7,240,000USD | 10,654,078USD | 726,039USD | -6,310,386USD | -1,660,796USD | 792,555USD |
| Capital Expenditures | -58,000USD | -112,000USD | -871,000USD | -244,565USD | -485,999USD | -124,725USD | -1,587,717USD | -91,013USD |
| Free Cash Flow | 18,657,000USD | 4,777,000USD | -8,111,000USD | 10,409,513USD | 240,040USD | -6,435,111USD | -3,248,513USD | 701,542USD |
| Total Cashflows From Investing Activities | 68,000USD | -450,000USD | -25,337,000USD | -58,176,386USD | -485,999USD | -124,725USD | -10,582,086USD | -5,686,833USD |
| Net Borrowings | -8,000,000USD | -4,000,000USD | 36,020,000USD | 0USD | — | — | — | — |
| Total Cash From Financing Activities | -8,798,000USD | -4,911,000USD | 28,220,000USD | -18,950,777USD | 73,924,954USD | -1,900,793USD | 22,181,528USD | 8,685,739USD |
| Change In Cash | 9,985,000USD | -472,000USD | -4,357,000USD | -66,473,085USD | 74,164,994USD | -8,335,904USD | 9,938,646USD | 3,791,461USD |
| Begin Period Cash Flow | 13,380,000USD | 13,852,000USD | 18,209,000USD | 84,681,770USD | 10,516,776USD | 18,852,680USD | 8,914,034USD | 5,122,573USD |
| End Period Cash Flow | 23,365,000USD | 13,380,000USD | 13,852,000USD | 18,208,685USD | 84,681,770USD | 10,516,776USD | 18,852,680USD | 8,914,034USD |
| Other Cashflows From Investing Activities | 126,000USD | -338,000USD | -774,000USD | -163,560USD | -385,677USD | -56,684USD | -1,500,000USD | -56,651USD |
| Other Cashflows From Financing Activities | -1,150,000USD | -911,000USD | -278,000USD | 1,073,481USD | 3,253,418USD | -4,389,187USD | 877,702USD | 521,264USD |
| Unclassified Operating Cash Flow | 1,214,000USD | 1,449,000USD | — | — | — | — | — | — |
| Investments | — | -450,000USD | -17,820,274USD | -55,931,821USD | -485,999USD | -124,725USD | -10,582,086USD | -5,686,833USD |
| Sale Purchase Of Stock | — | -911,000USD | -7,522,000USD | -20,024,258USD | 75,535,767USD | 2,488,394USD | 22,181,528USD | 8,685,739USD |
| Unclassified Investing Cash Flow | — | — | -5,871,726USD | -1,836,440USD | — | — | 3,087,717USD | — |
| Change To Inventory | — | — | — | -816,589USD | -816,589USD | -2,207,163USD | -882,477USD | -93,219USD |
| Change To Liabilities | — | — | — | 1,450,125USD | 1,092,670USD | 1,141,573USD | -615,499USD | 104,659USD |
| Dividends Paid | — | — | — | -226USD | — | — | — | — |
| Issuance Of Capital Stock | — | — | — | 0USD | 70,671,536USD | 265,946USD | 21,303,826USD | 8,164,475USD |
| Cash And Cash Equivalents Changes | — | — | — | 74,164,994USD | 74,164,994USD | -8,335,904USD | 9,938,646USD | 3,791,461USD |
| Unclassified Financing Cash Flow | — | — | — | — | -4,864,231USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2025Yearly · 2025-12-31 | Product | Life Science Companies | 109,214,000 | USD | 0001448431-26-000005 |
| FY 2025Yearly · 2025-12-31 | Product | Other Revenue | 215,000 | USD | 0001448431-26-000005 |
| FY 2024Yearly · 2024-12-31 | Product | Life Science Companies | 85,469,000 | USD | 0001448431-26-000005 |
| FY 2024Yearly · 2024-12-31 | Product | Other Revenue | 6,658,000 | USD | 0001448431-26-000005 |
| Q3 2023Quarterly · 2023-09-30 | Product | Revenue Recognized At APoint In Time | 1,516,297 | USD | 0001213900-23-086885 |
| Q3 2023Quarterly · 2023-09-30 | Product | Revenue Recognized Over Time | 14,815,187 | USD | 0001213900-23-086885 |
| Q3 2022Quarterly · 2022-09-30 | Product | Revenue Recognized At APoint In Time | 581,562 | USD | 0001213900-23-086885 |
| Q3 2022Quarterly · 2022-09-30 | Product | Revenue Recognized Over Time | 14,503,942 | USD | 0001213900-23-086885 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.